Monoclonal Antibodies for COVID-19 in Children: Case Series Should be Just the Start

Zheyi Teoh1, Zachary I Willis2

  • 1Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Insights

Two new studies guide pediatric COVID-19 treatment using monoclonal antibodies. Further research is essential for monoclonal antibodies and other therapies in children.

Area of Science:

  • Pediatric infectious diseases
  • Immunology
  • Pharmacology

Background:

  • COVID-19 presents unique challenges in pediatric populations.
  • Monoclonal antibodies have emerged as a potential therapeutic option.
  • Guidance for pediatric use of these therapies is developing.